Difference between revisions of "Ferric carboxymaltose (Injectafer)"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
||
Line 24: | Line 24: | ||
[[Category:Iron]] | [[Category:Iron]] | ||
− | [[Category: | + | [[Category:FDA approved in 2013]] |
Revision as of 19:03, 30 July 2018
General information
Class/mechanism: Colloidal iron (III) hydroxide in complex with carboxymaltose, a carbohydrate polymer that releases iron.[1][2][3]
Route: IV
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Patient drug information
History of changes in FDA indication
- 7/25/2013: FDA approved "for the treatment of iron deficiency anemia in adult patients:
- who have intolerance to oral iron or have had unsatisfactory response to oral iron
- who have non–dialysis-dependent chronic kidney disease."
Also known as
- Brand name: Injectafer